---
title: "本週全球重要新聞：葛蘭素史克、三星電子和滙豐控股等知名公司位列其中"
description: "美國股指上漲，受到主要銀行強勁財報的提振。標準普爾 500 指數和納斯達克分別上漲 0.2% 和 0.6%，而道瓊斯指數下跌 0.2%。在歐洲，股市下跌 0.7%，因為歐洲央行維持利率不變。葛蘭素史克和滙豐控股報告了積極的財報，而斯特蘭蒂斯則面臨指控。在亞洲，結果喜憂參半，三星在內存芯片方面創下了收入紀錄，而比亞迪的利潤下降了 33%。日本銀行維持利率不變，暗示未來的加息將取決於經濟狀況"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/263906494.md"
published_at: "2025-11-02T17:30:10.000Z"
---

# 本週全球重要新聞：葛蘭素史克、三星電子和滙豐控股等知名公司位列其中

> 美國股指上漲，受到主要銀行強勁財報的提振。標準普爾 500 指數和納斯達克分別上漲 0.2% 和 0.6%，而道瓊斯指數下跌 0.2%。在歐洲，股市下跌 0.7%，因為歐洲央行維持利率不變。葛蘭素史克和滙豐控股報告了積極的財報，而斯特蘭蒂斯則面臨指控。在亞洲，結果喜憂參半，三星在內存芯片方面創下了收入紀錄，而比亞迪的利潤下降了 33%。日本銀行維持利率不變，暗示未來的加息將取決於經濟狀況

US stock indexes ended the week higher, supported by encouraging earnings reports from major U.S. banks. Out of the 173 S&P 500 companies that reported earnings this week, 142 of them beat EPS estimates, while 127 of those names surpassed revenue expectations. Meanwhile, the Federal Reserve cut interest rates by a quarter point in October 2025, al...

### Related Stocks

- [SSNGY.US - 三星電子](https://longbridge.com/zh-HK/quote/SSNGY.US.md)
- [HSBC.US - 滙豐](https://longbridge.com/zh-HK/quote/HSBC.US.md)
- [00005.HK - 匯豐控股](https://longbridge.com/zh-HK/quote/00005.HK.md)
- [GSK.UK - 葛蘭素史克](https://longbridge.com/zh-HK/quote/GSK.UK.md)
- [GSK.US - 葛蘭素史克](https://longbridge.com/zh-HK/quote/GSK.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| GSK Recieves Approval For Exdensur From The European Commission | GSK plc :GSK PLC - EXDENSUR APPROVED BY THE EUROPEAN COMMISSIONGSK PLC - EXDENSUR APPROVED BY THE EUROPEAN COMMISSION | [Link](https://longbridge.com/zh-HK/news/276102835.md) |
| GSK Begins Up to GBP450 Million Share Buyback Tranche | GSK Begins Up to GBP450 Million Share Buyback Tranche | [Link](https://longbridge.com/zh-HK/news/276103252.md) |
| Berenberg Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK) | Berenberg Bank analyst Kerry Holford has maintained a Hold rating on GlaxoSmithKline (GSK) with a price target of £20.00 | [Link](https://longbridge.com/zh-HK/news/276103203.md) |
| GSK Begins Fourth Tranche Of Up To GBP 0.45 Bln Share Buyback Under GBP 2 Bln Programme | British drug major GSK plc has announced the commencement of the fourth tranche of its £2 billion share buyback program, | [Link](https://longbridge.com/zh-HK/news/276103384.md) |
| Exdensur approved in EU for severe asthma and CRSwNP | GSK has received European Commission approval for Exdensur (depemokimab), the first ultra-long-acting biologic for sever | [Link](https://longbridge.com/zh-HK/news/276226507.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。